7篇
您的检索式：作者名="de Alwis DP"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A Phase I trial of a potent P-glycoprotein inhibitor, zosuquidar trihydrochloride ( LY335979 ) , administ-ered intravenously in combination with doxorubicin in patients with advanced malignancy 显示文摘 | Sandier A Gordon M De Alwis DP | 2004 | Clin Cancer Res2004，10，10： | 1 |
| 2 | A Phase I trial of a po2tent P2glycop rotein inhibitor, zosuquidar trihydrochloride (LY335979), administered intravenously in combination with doxo mbicin in patientswith advanced malignancy 显示文摘 | Sandier A Gordon M De Alwis DP | 2004 | C/in Cancer Res2004，10，10： | 1 |
| 3 | A Phase I trial of a potent P-glycoprotein inhibitor, zosuquidar trihydrochloride (LY335979), administered intravenously in combination with doxorubicin in patients with advanced malignancy显示文摘 | Sandler A Gordon M De Alwis DP | 2004 | Clin Cancer Res2004，10，10： | 1 |
| 4 | A phaseⅠtrial of a potent P-glycoprotein inhibitor,zosuquidar trihydrochloride(LY335979),administered intravenously in combination with doxorubicin in patients with advanced malignancy显示文摘 | Sandler A Gordon M de Alwis DP | 2004 | Clin Cancer Res2004，10，10： | 1 |
| 5 | A phase I trial of a potent P-glycoprotein inhibitor, zosuquidar trihydrochloride(LY335979),administered orally in combinatian with doxombicin in patients with advanced malignancies显示文摘 | Rubin EH de Alwis DP Pouliquen I | 2002 | Clin Cancer Res2002，8，12： | 1 |
| 6 | A phase I trial of a potent P-glycoprotein inhibitor, zosuquidar trihydrochloride ( LY335979 ),administered intravenously in combination with doxorubicin in patients with advanced malignancy显示文摘 | Sandler A Gordon M De Alwis DP | 2004 | Clin Cancer Res2004，10，10： | 1 |
| 7 | A population pharmacokinetic model for paclitaxel in the presence of a novel P-gp modulator, Zosuquidar trihydrochloride (LY335975) 显示文摘 | Callies S de Alwis DP Harris A | 2003 | Br J Clin Pharmacol2003，56，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员